Back to search

University of Minnesota

Delivery and efficacy of targeted therapeutics and imaging agents for brain tumors

Abstract

dc:description.abstract

The treatment of both primary and secondary brain tumors is a serious unmet medical need in the field of neuro-oncology. Despite advances in developing molecularly-targeted anti-cancer therapeutics in treating peripheral tumors, there is no effective therapeutic for brain tumors that demonstrated dramatic improvement in patient survival. One of the major reasons of having lack of efficacy in central nervous system may be related to the delivery of therapeutic agents across the blood-brain barrier (BBB). The BBB expresses various transporters as well as unique junctional proteins that selectively permeate molecules into the brain from systemic circulation. Many molecularly-targeted therapeutic agents are found to be substrates of these efflux transporters at the BBB including P-glycoprotein (P-gp) and Breast cancer resistance protein (Bcrp). The current dissertation examined the multiple challenges in the treatment of brain tumors including non-specific protein binding, brain distributional kinetics, and role of efflux transporters on the distribution of various molecules such as molecularly-targeted anti-cancer drugs and tumor imaging agents.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kim, Minjee

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Citation
Kim, Minjee. (2018). Delivery and efficacy of targeted therapeutics and imaging agents for brain tumors. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/201690.

Chain of custody

source
Harvested from
University of Minnesota
Base URL
conservancy.umn.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Kim, Minjee. Delivery and efficacy of targeted therapeutics and imaging agents for brain tumors. 2018. http://hdl.handle.net/11299/201690